1. Home
  2. APYX vs OCUP Comparison

APYX vs OCUP Comparison

Compare APYX & OCUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • OCUP
  • Stock Information
  • Founded
  • APYX 1982
  • OCUP 2018
  • Country
  • APYX United States
  • OCUP United States
  • Employees
  • APYX N/A
  • OCUP N/A
  • Industry
  • APYX Medical/Dental Instruments
  • OCUP Biotechnology: Pharmaceutical Preparations
  • Sector
  • APYX Health Care
  • OCUP Health Care
  • Exchange
  • APYX Nasdaq
  • OCUP Nasdaq
  • Market Cap
  • APYX 47.1M
  • OCUP 53.1M
  • IPO Year
  • APYX 1987
  • OCUP N/A
  • Fundamental
  • Price
  • APYX $1.28
  • OCUP $1.32
  • Analyst Decision
  • APYX Buy
  • OCUP Strong Buy
  • Analyst Count
  • APYX 2
  • OCUP 3
  • Target Price
  • APYX $5.00
  • OCUP $18.67
  • AVG Volume (30 Days)
  • APYX 43.4K
  • OCUP 86.6K
  • Earning Date
  • APYX 11-07-2024
  • OCUP 11-11-2024
  • Dividend Yield
  • APYX N/A
  • OCUP N/A
  • EPS Growth
  • APYX N/A
  • OCUP N/A
  • EPS
  • APYX N/A
  • OCUP N/A
  • Revenue
  • APYX $49,031,000.00
  • OCUP $16,449,000.00
  • Revenue This Year
  • APYX N/A
  • OCUP N/A
  • Revenue Next Year
  • APYX $6.20
  • OCUP $258.69
  • P/E Ratio
  • APYX N/A
  • OCUP N/A
  • Revenue Growth
  • APYX 3.36
  • OCUP N/A
  • 52 Week Low
  • APYX $0.97
  • OCUP $1.15
  • 52 Week High
  • APYX $3.46
  • OCUP $3.53
  • Technical
  • Relative Strength Index (RSI)
  • APYX 55.39
  • OCUP 48.70
  • Support Level
  • APYX $1.14
  • OCUP $1.25
  • Resistance Level
  • APYX $1.24
  • OCUP $1.35
  • Average True Range (ATR)
  • APYX 0.09
  • OCUP 0.08
  • MACD
  • APYX 0.01
  • OCUP 0.01
  • Stochastic Oscillator
  • APYX 77.27
  • OCUP 29.17

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About OCUP Ocuphire Pharma Inc.

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

Share on Social Networks: